CRIS vs IMMX

Head-to-Head Stock Analysis & Investment Rating

Last Updated: Sep 29, 2026

CRIS

38.8
AI Score
VS
IMMX Wins

IMMX

51.0
AI Score

Investment Advisor Scores

CRIS

39score
Recommendation
SELL

IMMX

51score
Recommendation
HOLD

AI Analyst Insights

AI insights temporarily unavailable

Detailed Metrics Comparison

Metric CRIS IMMX Winner
Revenue 9.44M 20.00M IMMX
Net Income -7.58M -21.64M CRIS
Net Margin -80.3% -108.2% CRIS
Operating Income -5.71M -23.26M CRIS
ROE -138.8% -9.5% IMMX
ROA -38.0% -9.1% IMMX
Total Assets 19.97M 239.11M IMMX
Cash 5.06M 225.49M IMMX
Current Ratio 0.49 25.13 IMMX

Relative Price Performance (Last 90 Days)

CRIS 1M: -41.8% · 3M: -86.5% IMMX 1M: -30.7% · 3M: -7.4%

Current Technical Phase

CRIS

Markdown
Sell / avoid

Price below a falling SMA50 (slope -32.4%), weak momentum, RSI 23

RSI (14): 23.0 · Price: $0.80

IMMX

Neutral
Hold

Mixed signals - no dominant trend phase, RSI 31

RSI (14): 31.4 · Price: $9.68

Fundamentals Snapshot

Metric CRIS IMMX
Market Cap — —
Forward P/E -0.1 -11.4
Trailing P/E 0.2 —
Revenue (TTM) — —
Revenue Growth -0.7% 0.0%
Gross Margin -4.9% —
Operating Margin -8.3% 0.0%
EPS 3.65 -0.88
Dividend Yield — —

Frequently Asked Questions

Based on our detailed analysis, IMMX is currently the stronger investment candidate, winning 6 of the key financial metrics based on our comprehensive scoring model.

We analyze revenue and earnings growth rates in the "Growth" section above. Generally, the company with higher year-over-year revenue and EPS growth is fostering better expansion. Check the table above for the specific growth percentages.

Valuation is determined by metrics like the P/E Ratio and PEG Ratio. A lower P/E typically suggests a stock is cheaper relative to its earnings. Refer to the "Valuation" section in our comparison table to see which stock currently trades at a more attractive multiple.